Advertisement

Topics

Zanos et al. reply

09:09 EDT 22 Jun 2017 | Nature Publishing

Replying to K. Suzuki et al. Nature546, http://dx.doi.org/10.1038/nature22084 (2017)In the accompanying Comment, Suzuki et al. confirmed our previous findings that the ketamine metabolite (2R,6R)-hydroxynorketamine (HNK) does not functionally inhibit the NMDAR at

Original Article: Zanos et al. reply

NEXT ARTICLE

More From BioPortfolio on "Zanos et al. reply"

Advertisement
Quick Search
Advertisement
Advertisement